Skip to main content
. 2024 Jan 2;10:2. doi: 10.1038/s41523-023-00605-3

Table 7.

Treatment of HER+ patient cohort (TMAs 226 and 227).

Treatment # pts in TMAs 226 and 227 (n = 189) # pts in ITH cohort (n = 77)
Chemotherapy 33 18
Hormone therapy 25 6
Chemotherapy + hormone therapy 85 33
Chemotherapy + trastuzumab 6 4
Chemo + hormone + trastuzumab 12 6
n/a 28 10